Latest Market Expectations News

Amplitude Energy Limited has announced a proposed 11-for-1 share consolidation, pending shareholder approval at its upcoming AGM. This move aims to streamline its capital structure following a recent entitlement offer.

Castle Minerals has launched a comprehensive soil sampling program in Côte d’Ivoire alongside accelerated auger drilling in Ghana, targeting prolific Birimian gold terranes to uncover new mineralisation.

G11 Resources Limited has revised the timetable for its planned 10-for-1 security consolidation, affecting ordinary shares and multiple option classes with adjusted exercise prices and quantities.

Nelson Resources has confirmed it is in confidential negotiations for a Right to Mine contract, explaining recent unusual trading activity in its shares. The company maintains compliance with ASX disclosure rules while awaiting contract finalisation.

Myer Holdings has clarified that its FY2025 earnings aligned with market forecasts, addressing concerns following a sharp share price drop after its results announcement.

Invictus Energy has responded to an ASX inquiry about unusual trading activity, clarifying that recent price and volume changes followed a disclosed deferral of a placement tied to a strategic joint venture.

Aguia Resources has responded to an ASX price query following a dramatic surge in its share price, confirming no new material exploration results have been received or withheld. The company asserts full compliance with continuous disclosure obligations despite market speculation.

Future Metals NL has responded to an ASX price query following a sharp rise in its share price and trading volume, confirming no undisclosed information but highlighting progress on appointing a new CEO.

Renergen Limited forecasts a significant increase in its loss per share for the six months ending August 2025, driven by one-off transaction expenses and full commissioning costs of its Phase 1 plant.

Bank of Queensland Limited announces a fully franked quarterly distribution of AUD 1.2182 per Capital Note 3 security, reflecting a 4.89% annualised yield tied to the 3-month BBSW plus margin.

EVE Health Group has begun distributing Dyspro™, a novel cannabinoid-based treatment for dysmenorrhoea and endometriosis, through a national telehealth partnership. This launch targets a significant unmet need in women’s health with a growing global market.

CloudHolter Pty Ltd reported a substantial $39.7 million net loss for FY2025 amid ongoing cash outflows but continues to raise capital through convertible notes as it targets an IPO by year-end.